| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
98.66(B) |
| Last
Volume: |
9,075,310 |
Avg
Vol: |
8,465,245 |
| 52
Week Range: |
$48.64 - $68.84 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
69 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pierce David A |
SVP and President, Endoscopy |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,058 |
48,201 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$16,720 |
D/D |
(1,006) |
127,032 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,675 |
128,038 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & President, CRM |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$38,276 |
D/D |
(2,303) |
118,138 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & President, CRM |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,778 |
120,441 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$13,213 |
D/D |
(795) |
18,737 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,102 |
19,532 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$227,428 |
D/D |
(13,684) |
1,197,416 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,051 |
1,211,100 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$35,916 |
D/D |
(2,161) |
305,721 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,587 |
307,882 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$13,047 |
D/D |
(785) |
36,070 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,484 |
36,855 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$13,878 |
D/D |
(835) |
83,916 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,484 |
84,751 |
|
- |
|
| Bose Supratim |
EVP & President, Asia-Pacific |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,675 |
106,444 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$16,005 |
D/D |
(963) |
54,664 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,866 |
55,627 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$17,966 |
D/D |
(1,081) |
171,061 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,293 |
172,142 |
|
- |
|
| Thepaut Eric Francis Yves |
SVP & Pres, Europe |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$5,601 |
D/D |
(337) |
88,352 |
|
- |
|
| Thepaut Eric Francis Yves |
SVP & Pres, Europe |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,529 |
88,689 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$26,941 |
D/D |
(1,621) |
130,907 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,440 |
132,528 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-23 |
4 |
D |
$16.31 |
$217,820 |
D/D |
(13,355) |
169,849 |
|
- |
|
2007 Records found
|
|
Page 4 of 81 |
|
|
0.97 (1.43%) 
